Prostate Cancer Video Channel
Explore the latest insights and summaries from experts in Prostate Cancer.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
The View on GU | with Lalani & Wallis
Primary Radiation Treatment for Prostate Cancer
- 85 views
- September 6, 2024
- 3
Yale Cancer Center
Surgical Management of High-Risk and Locally Advanced Prostate Cancer
FEATURING
Isaac Kim
- 465 views
- September 23, 2024
- 2
Advanced Prostate Cancer Consensus Conference (APCCC)
Total Therapy Considerations in Low-Volume mHSPC: Intensification vs. De-Intensification
FEATURING
Oliver Sartor
- 165 views
- October 23, 2024
- 4
International Urology Cancer Summit - IUCS
Patient-Friendly Fractionation for Curative Therapy of Localized Prostate Cancer
FEATURING
Alison Tree
- 68 views
- October 24, 2024
- 1
Advanced Prostate Cancer Consensus Conference (APCCC)
Management of Frail Patients With mHSPC
FEATURING
Maria De Santis
- 35 views
- October 25, 2024
Penn Medicine Abramson Cancer Center
Avoiding Unnecessary Operations in Prostate Cancer
FEATURING
Phillip Pierorazio
- 198 views
- November 8, 2024
- 1
Penn Medicine Abramson Cancer Center
Advances in Prostate Cancer Surgery
FEATURING
Benjamin Schurhamer,
Thomas Guzzo
- 223 views
- November 11, 2024
- 4
Oncology Data Advisor
Overcoming Disparities in Prostate Cancer Care
FEATURING
Waqas Haque
- 11 views
- November 14, 2024
Yale Cancer Center
Theranostics and Advanced Treatment Options for Prostate Cancer
FEATURING
Gabriela Spilberg
- 114 views
- May 6, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 566 views
- July 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Prostate Cancer Take-Home Messages
FEATURING
Eleni Efstathiou
- 598 views
- July 29, 2024
- 2
Nebraska Oncology Society
Updates on Treatment Options for mCRPC
FEATURING
Nataliya Mar
- 141 views
- July 30, 2024
University of Miami Sylvester Comprehensive Cancer Center
Precision Therapies for Prostate Cancer
FEATURING
Marijo Bilusic
- 391 views
- August 20, 2024
- 5
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 14 views
- September 5, 2024
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 27 views
- September 6, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Radioligand Therapies in Prostate Cancer
FEATURING
Natalie Reizine,
Karine Tawagi
- 79 views
- October 10, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Bladder and RCC Highlights
FEATURING
Karine Tawagi,
Natalie Reizine
- 113 views
- October 10, 2024
- 1
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 24 views
- October 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Shaping Prostate Cancer Trials
FEATURING
Eleni Efstathiou
- 102 views
- October 15, 2024
ecancer
ESMO 2024 Insights: Best Practice in HRRm Testing in Patients With Metastatic Prostate Cancer
- 93 views
- October 16, 2024
ecancer
ESMO 2024: Optimizing the Personalization of Prostate Cancer Treatment
- 48 views
- October 22, 2024
International Urology Cancer Summit - IUCS
Evolving Strategies in First and Second-Line Treatment for mCRPC
FEATURING
Neeraj Agarwal
- 227 views
- October 23, 2024
- 2
The View on GU | with Lalani & Wallis
Review of mCRPC Updates From ESMO 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 77 views
- October 30, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Future Changes in the Setting of mHSPC
FEATURING
Gerhardt Attard
- 40 views
- November 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Guidance on Optimal Candidates for Triplet Systemic Therapy in mHSPC: ADT + Docetaxel + ARPI
FEATURING
Nicholas James
- 65 views
- November 5, 2024
- 1
Emmanuel Seront
Update on Systemic Treatments for Metastatic Prostate Cancer
- 104 views
- November 8, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC
FEATURING
Karim Fizazi
- 178 views
- November 19, 2024
Beth Israel Deaconess Medical Center
Personalizing Treatment Selection in mHSPC
FEATURING
David Einstein
- 35 views
- November 20, 2024
Yale Cancer Center
Updates in Radioligand Therapies for Metastatic Prostate Cancer
FEATURING
William Oh
- 105 views
- November 20, 2024
- 1
University of Illinois Cancer Center
Overview of Homologous Recombination Deficiencies & PARPi in mCRPC
FEATURING
Karine Tawagi
- 269 views
- March 5, 2024
- 2
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
FEATURING
Jacob Berchuck,
Atish Choudhury
- 335 views
- March 13, 2024
- 2
UCLA Health
Managing Advanced Prostate Cancer Pts in Urology Clinics and When to Refer to Medical Oncologists
FEATURING
Isla Garraway
- 175 views
- March 18, 2024
- 1
Michigan Urological Surgery Improvement Collaborative (MUSIC)
MUSIC Experience With High-Risk Prostate Cancer
FEATURING
Alice Semarijan
- 9 views
- June 5, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Radiation to the Primary in High Volume mHSPC
FEATURING
Sandy Srinivas
- 24 views
- December 4, 2024
International Urology Cancer Summit - IUCS
Treatment (De)Intensification in mHSPC
FEATURING
Pasquale Rescigno
- 18 views
- December 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Combination Systemic Therapy vs. ADT+RT in mHSPC
FEATURING
Robert Jones
- 2 views
- December 6, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Considerations for De-Escalation and Treatment Breaks in mHSPC Management
FEATURING
Bertrand Tombal
- 11 views
- December 6, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Ideal Treatment Sequence After ADT + ARPI or ADT Alone for mHSPC
FEATURING
Ian Davis
- 6 views
- December 9, 2024
University of Illinois Cancer Center
Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
FEATURING
Karine Tawagi
- 10 views
- December 12, 2024
Therapeutic Agents
Alice Bernard-Tessier
Searching for I-O in Prostate Cancer: Unraveling the Role of Immunotherapy
- 156 views
- May 10, 2024
Cedars Sinai
Comparing Adverse Event Rates by Race Among ADT-Treated vs. Non-ADT-Treated Prostate Cancer Patients
FEATURING
Nadine Friedrich
- 177 views
- August 27, 2024
Penn Medicine Abramson Cancer Center
Improving QoL During and After Treatment in Prostate Cancer
FEATURING
Cailyn Chow,
Robert Caleb Kovell
- 46 views
- November 15, 2024
- 1
University of Illinois Cancer Center
Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer
FEATURING
Karine Tawagi,
Natalie Reizine
- 167 views
- December 2, 2024
- 5
Yale Cancer Center
Theranostics and Advanced Treatment Options for Prostate Cancer
FEATURING
Gabriela Spilberg
- 114 views
- May 6, 2024
Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents in mHSPC and CRPC"
FEATURING
David Jarrard
- 383 views
- May 23, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"
FEATURING
Tilman Todenhöfer
- 57 views
- June 19, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 79 views
- June 20, 2024
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in Metastatic Prostate Cancer: Genomic Markers and Theranostics
FEATURING
Rohan Garje
- 373 views
- June 26, 2024
- 3
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 14 views
- September 5, 2024
Houston Methodist
Developing Local Delivery of Anti-Androgen Therapy: A Novel Treatment for Prostate Diseases
FEATURING
Pamela Munster
- 20 views
- September 19, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerated 177Lu-PSMA-617 in mHSPC
FEATURING
Minal Padden-Modi,
Nick James
- 68 views
- September 25, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: INSPIRE Trial - Nivolumab and Ipilimumab in Molecularly Selected mCRPC Patients
FEATURING
Niven Mehra
- 126 views
- October 1, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Radioligand Therapies in Prostate Cancer
FEATURING
Natalie Reizine,
Karine Tawagi
- 79 views
- October 10, 2024
- 1
ecancer
ESMO 2024 Insights: PEACE-3 Trial - Enzalutamide Treatment Boosted by Radium-223 in mCRPC
FEATURING
Silke Gillessen
- 57 views
- October 11, 2024
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 24 views
- October 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Circulating Tumor Cell Enumeration and OS in mCRPC Treated With Xaluritamig
FEATURING
Andrew Armstrong
- 33 views
- October 14, 2024
International Urology Cancer Summit - IUCS
Evolving Strategies in First and Second-Line Treatment for mCRPC
FEATURING
Neeraj Agarwal
- 227 views
- October 23, 2024
- 2
Advanced Prostate Cancer Consensus Conference (APCCC)
PARP Inhibition (Dissected): Determining Who Benefits in mCRPC
FEATURING
Johann de Bono
- 52 views
- November 5, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Best Use of PARP Inhibitors in mCRPC With BRCA1/2 Alterations
FEATURING
Joaquin Mateo
- 22 views
- November 5, 2024
Masonic Cancer Center, University of Minnesota
Targeting RET Kinase in Neuroendocrine Prostate Cancer
FEATURING
Justin Drake
- 12 views
- November 7, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing mHSPC With Early Progression on Combination Therapy
FEATURING
Christopher Sweeney
- 6 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing Side Effects of PARP Inhibitors in mCRPC
FEATURING
Elena Castro
- 18 views
- November 12, 2024
Yale Cancer Center
Updates in Radioligand Therapies for Metastatic Prostate Cancer
FEATURING
William Oh
- 105 views
- November 20, 2024
- 1
University of Illinois Cancer Center
Diagnostic and Therapeutic Updates in mCRPC: Radioligand Therapy
FEATURING
Karine Tawagi
- 192 views
- March 5, 2024
- 5
University of Illinois Cancer Center
Overview of Homologous Recombination Deficiencies & PARPi in mCRPC
FEATURING
Karine Tawagi
- 269 views
- March 5, 2024
- 2
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
FEATURING
Jacob Berchuck,
Atish Choudhury
- 335 views
- March 13, 2024
- 2
Jochen Walz
Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC
- 178 views
- March 18, 2024
Maneesh Jain
Evaluating Safety and Efficacy of T-DXd as a Subsequent Line Therapy in HER2+ mCRPC
- 4 views
- December 11, 2024
University of Illinois Cancer Center
Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
FEATURING
Karine Tawagi
- 10 views
- December 12, 2024
Diagnostics & Biomarkers
University of Illinois Cancer Center
Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer
FEATURING
Karine Tawagi,
Natalie Reizine
- 167 views
- December 2, 2024
- 5
ecancer
The Value of Identifying BRCA1 & BRCA2 Mutations for mCRPC Outcomes
FEATURING
Guilhem Roubaud
- 52 views
- April 26, 2024
Yale Cancer Center
Theranostics and Advanced Treatment Options for Prostate Cancer
FEATURING
Gabriela Spilberg
- 114 views
- May 6, 2024
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in Metastatic Prostate Cancer: Genomic Markers and Theranostics
FEATURING
Rohan Garje
- 373 views
- June 26, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 566 views
- July 10, 2024
- 2
Oncology Data Advisor
Interpreting PSA Values in Transgender Women for Optimal Prostate Cancer Screening
FEATURING
Stephen Freedland,
Farnoosh Nik-Ahd
- 105 views
- August 14, 2024
- 1
University of Miami Sylvester Comprehensive Cancer Center
Precision Therapies for Prostate Cancer
FEATURING
Marijo Bilusic
- 391 views
- August 20, 2024
- 5
Anwar Padhani
Engineering the Future of Imaging-Based Diagnostics and Therapeutics for Prostate Cancer
FEATURING
Anwar Padhani
- 85 views
- September 17, 2024
- 2
Anwar Padhani
Next-Generation Imaging for High-Risk Locally Advanced Prostate Cancer: When to Use It
FEATURING
Anwar Padhani
- 48 views
- September 17, 2024
Anwar Padhani
Prostate Cancer Diagnosis Pathway: 2024 Update
FEATURING
Anwar Padhani
- 887 views
- September 17, 2024
- 7
Anwar Padhani
Prostate Cancer Detection Software in 2024: What to Think About Before You Buy
FEATURING
Anwar Padhani
- 54 views
- September 17, 2024
Anwar Padhani
Prostate Cancer Screening: Lessons From the MRI Studies
FEATURING
Anwar Padhani
- 63 views
- September 17, 2024
- 1
Anwar Padhani
MRI in Prostate Cancer Screening: Time to Reset?
FEATURING
Anwar Padhani
- 52 views
- September 17, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Predictive Tumor Suppressor Gene Signature for Early Progression in mHSPC
FEATURING
Marta Garcia De Herreros
- 24 views
- September 20, 2024
COR2ED The Heart of Medical Education
Precision Oncology in Practice: Testing to Treatment in Lung and Prostate Cancer
FEATURING
Fernando López-Ríos
- 28 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: INSPIRE Trial - Nivolumab and Ipilimumab in Molecularly Selected mCRPC Patients
FEATURING
Niven Mehra
- 126 views
- October 1, 2024
- 2
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 24 views
- October 11, 2024
ecancer
ESMO 2024 Insights: Best Practice in HRRm Testing in Patients With Metastatic Prostate Cancer
- 93 views
- October 16, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Relevant Prognostic and Predictive Factors in mHSPC
FEATURING
Matthew Smith
- 41 views
- October 30, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Recommended Imaging Standards for mHSPC in Daily Practice
FEATURING
Michael Morris
- 93 views
- November 4, 2024
- 1
Advanced Prostate Cancer Consensus Conference (APCCC)
Future Changes in the Setting of mHSPC
FEATURING
Gerhardt Attard
- 40 views
- November 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
PARP Inhibition (Dissected): Determining Who Benefits in mCRPC
FEATURING
Johann de Bono
- 52 views
- November 5, 2024
Oncology Data Advisor
The Urologist and Oncologist Perspectives on Advancements and Disparities in Prostate Cancer
FEATURING
Stephen Freedland,
Ulka Vaishampayan
- 19 views
- November 5, 2024
Laurence Klotz
Visible vs. Invisible Cancers - The Genomics and Natural History
- 197 views
- November 6, 2024
- 2
Masonic Cancer Center, University of Minnesota
Proteomic Approaches to Nominate Drug Targets and Assess Biomarkers in Prostate Cancer
FEATURING
Justin Drake
- 39 views
- November 7, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Guidelines for Tumor Genomic Profiling in Advanced Prostate Cancer
FEATURING
Niven Mehra
- 35 views
- November 8, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing mHSPC With Early Progression on Combination Therapy
FEATURING
Christopher Sweeney
- 6 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Optimizing Escalation Strategies for mHSPC With Unfavorable PSA Declines
FEATURING
Mary-Ellen Taplin
- 9 views
- November 11, 2024
Penn Medicine Abramson Cancer Center
Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024
FEATURING
Daniel Lee
- 293 views
- November 12, 2024
- 1
Yale Cancer Center
Updates in Radioligand Therapies for Metastatic Prostate Cancer
FEATURING
William Oh
- 105 views
- November 20, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
From CHAARTED Low- and High-Volume Disease to PSMA PET Imaging Volume in mHSPC
FEATURING
Lena Unterrainer
- 108 views
- March 5, 2024
University of Illinois Cancer Center
Diagnostic and Therapeutic Updates in mCRPC: Radioligand Therapy
FEATURING
Karine Tawagi
- 192 views
- March 5, 2024
- 5
University of Illinois Cancer Center
Overview of Homologous Recombination Deficiencies & PARPi in mCRPC
FEATURING
Karine Tawagi
- 269 views
- March 5, 2024
- 2
Insights from 2024 ASCO® GU Annual Meeting
Real-World Genomic Testing Patterns in Patients With Prostate Cancer
FEATURING
Dalia Kaakour
- 180 views
- March 13, 2024
- 1
Oncology Data Advisor
National Cancer Prevention Month: Lowering Prostate Cancer Risk
FEATURING
Stephen Freedland,
William Aronson
- 52 views
- March 14, 2024
- 1
UCLA Health
Managing Advanced Prostate Cancer Pts in Urology Clinics and When to Refer to Medical Oncologists
FEATURING
Isla Garraway
- 175 views
- March 18, 2024
- 1
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Current Status of PSMA PET in the US
FEATURING
Thomas Hope
- 8 views
- June 5, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
PSMA PET Imaging
FEATURING
Matthew Cooperberg
- 369 views
- June 5, 2024
- 3
International Urology Cancer Summit - IUCS
Treatment (De)Intensification in mHSPC
FEATURING
Pasquale Rescigno
- 18 views
- December 4, 2024
Weill Cornell Medicine Oncology & Hematology
Understanding PSMA in Advanced Prostate Cancer and Its Impact on Treatment Decisions
FEATURING
David Nanus
- 42 views
- December 10, 2024
Mark Emberton
MRI-Based Prostate Cancer Screening and Insights From the TRANSFORM Project
- 2 views
- December 10, 2024
University of Illinois Cancer Center
Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
FEATURING
Karine Tawagi
- 10 views
- December 12, 2024
Disease Overview
Houston Methodist
Cancer Prevention, Control, and Population Sciences: Insights From Prostate Cancer and Beyond
FEATURING
Jennifer Cullen
- 67 views
- September 10, 2024
University of Miami Sylvester Comprehensive Cancer Center
Precision Therapies for Prostate Cancer
FEATURING
Marijo Bilusic
- 391 views
- August 20, 2024
- 5
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Surgery for High-Risk Prostate Cancer
FEATURING
James Peabody
- 159 views
- June 5, 2024
- 1
Yale Cancer Center
Surgical Options for the Care of Prostate Cancer
FEATURING
Michael Leapman,
Eric Winer
- 11 views
- December 11, 2024
Case Studies
ecancer
57 y/o Patient With Triple Coronary Bypass and PSA>900 ng/ml: High Risk De Novo Metastatic Prostate Cancer Case Discussion
FEATURING
Guilhem Roubaud
- 39 views
- April 26, 2024
